$RAPP SEC Filings

Filed On	Filing
23 Oct 2026	Form 4: Ceesay Abraham, Director Sold 2,210 shares ($64.4K)
23 Oct 2026	Form 4: Sanchez Ramiro, Director Bought 3,600 shares ($98.5K)
22 Oct 2026	Form 4: Silva Paul M, Director Bought 3,680 shares ($99.6K)
22 Oct 2026	Form 4: Young Wendy B., Director Bought 3,789 shares ($100K)
22 Oct 2026	Form 4: Paul Steven M, Director Bought 35,714 shares ($974K)
22 Oct 2026	Form 4: Maraganore John, Director Bought 9,411 shares ($249K)
21 Oct 2026	Form 4: Ignelzi Troy A., Chief Financial Officer Bought 5,500 shares ($144K)
20 Oct 2026	8-K: Regulation FD Disclosure; Other Events Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania
08 Oct 2026	Form 4: Ceesay Abraham, Director Sold 3,375 shares ($108K) · Sold 1,147 shares ($35.2K)
06 Oct 2026	144
01 Oct 2026	Form 4: Gault Cheryl, Chief Operating Officer Sold 10,000 shares ($332K)
30 Sep 2026	144
24 Sep 2026	Form 4: Ceesay Abraham, Director Sold 2,210 shares ($86.6K)
09 Sep 2026	Form 4: Ceesay Abraham, Director Sold 8,210 shares ($374K)
26 Aug 2026	Form 4: Ceesay Abraham, Director Sold 18,921 shares ($938K)
26 Aug 2026	Form 4: Yeleswaram Krishnaswamy, Chief Development Officer Sold 13,160 shares ($658K) · Sold 37,000 shares ($1.87M)
25 Aug 2026	144
24 Aug 2026	144
20 Aug 2026	Form 4: Yeleswaram Krishnaswamy, Chief Development Officer Sold 404 shares ($20.2K)
19 Aug 2026	144

Comments